Can a tapeworm drug boost protection from Covid-19 for high-risk kidney patients? | Cambridge Immunology Network

skip to content

Submitted by J.M. Arasteh on Tue, 23/02/2021 - 10:16

UK researchers are launching a clinical trial to investigate if the drug niclosamide, usually used to treat tapeworms, can prevent Covid-19 infection in vulnerable, high-risk kidney patients and reduce the number of people who become seriously ill or die from it.

Read the original article here>